glp-1 intestinal paralysis lawsuit in michigan The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know As insurers struggle with GLP-1
Description
The next step is getting clear on what path youre taking
Here's to ongoing innovation and improved patient care
Cardiometabolic implications of postpartum weight changes in the first year after delivery
GLP-1 medications have quickly become one of the most complicated conversations happening in employee benefits in 2026
Many GLP-1 programs, including TrimRx, allow patients to discuss switching medications with their provider if their current treatment is not producing the desired results
Ready to Achieve Sustainable Weight Loss with Expert Guidance and Real Results
